The Effect of Korean Medical Combination Treatment on 72 Cases of Herniated Intervertebral Lumbar Disc Patients: An Observational Study

Article information

Acupunct. 2015;32(2):23-33
1Department of Acupuncture & Moxibusion Medicine, Daejeon Jaseng Hospital of Korean Medicine
2Department of Oriental Internal Medicine, Daejeon Jaseng Hospital of Korean Medicine
3Department of Oriental Rehabilitation Medicine, Daejeon Jaseng Hospital of Korean Medicine
*Corresponding author: Department of Acupuncture & Moxibusion Medicine, Daejeon Jaseng Hospital of Korean Medicine, 58, Munjeong-ro 48beon-gil, Seo-gu, Daejeon, 302-859, Republic of Korea, Tel: +82-10-9407-6216, E-mail: goksmgo@naver.com
Received 2015 April 17; Revised 2015 May 21; Accepted 2015 May 26.

Abstract

Objectives:

This study was designed to assess the general distribution and clinical effectiveness of Korean medical treatment on lumbar disc herniation.

Methods:

This is an observational study. 72 patients admitted to Daejeon Jaseng Hospital of Korean Medicine with a diagnosis of herniated intervertebral disc(HIVD) by lumbar-CT of lumbar-MRI were observed from July, 2014 to April, 2015. They were analyzed according to sex, age, the period of disease, causal factors, symptoms on admission, admission day, disc herniation type and treatment efficacy. All patients received a combination of treatments during hospitalization, including acupuncture, Chuna, herbal medicines and physical therapy. A zero to ten numerating rating scale(NRS) assessing pain, Oswestry disability index(ODI) and EuroQol-5 dimension(EQ-5D) was used before and after treatments.

Results:

Average admission duration was 28.00±12.85 days in lumbar disc patients. For lumbar patients, lower back pain NRS decreased from 5.89±2.00 to 3.42± 1.87(p<0.001) and radiating pain from 5.96±2.12 to 3.38±1.83(p<0.001). ODI decreased from 46.69±19.25 to 35.69±16.67 (p<0.001), and EQ-5D index increased from 0.63±0.26 to 0.71±0.20(p<0.05) after treatment in lumbar disc patients.

Conclusions:

Korean medical combination treatment might be effective in reducing pain and improving quality of life for patients with lumbar disc herniation. This study further confirmed the efficacy of Korean medical treatment on HIVD.

Fig. 1.

Flow Diagram of Included Patients

Distribution of Sex and Age

Distribution of Causes

Distribution of Period of Illness

Distribution of Admission Days

Distribution of Numbers, Grade and Position of Herniation

Distribution of Pain Area

Lumbar Pain NRS Difference before and after Treatment

Radiating Pain NRS Difference before and after Treatment

ODI Difference before and after Treatment

EQ-5D Index Difference before and after Treatment

References

1. The Korean Orthopaedic Association. Orthopedics 6th editionth ed. Seoul: Choisin Medical Publishing Co; 2006. p. 617–30.
2. Gang HS, Hong SH, Gang CH. Musculoskeletal radiology 1st edth ed. Seoul: Bummun Education; 2013. p. 811–5.
3. Jensen MC. Magnetic resonance imaging of the lumbar spain in people without back pain. N Eng J Med 1994;331(2):69–73.
4. Lee GM, Lee GC, Hwang YJ. Collaborative study of oriental-western medicine on HIVD. The Acupuncture 2000;17(2):1–10.
5. Shvartzman L, Weingarten E, Sherry H, Levin C, Persaud A. Cost-effectiveness analysis of extended conservative therapy versus surgical intervention in the management of herniated lumbar intervertebral disc. Spine 1992;17(2):176–82.
6. Hurme M, Alaranta H. Factors perdicting the results of surgery of lumbar intervertebral disc herniation. Spine 1987;12(9):933–8.
7. Chen G, Yang S. Practical diagnostics and therapeutics of integrated traditional Chinese and western medicine Seoul: Iljoongsa; 1992. p. 1602.
8. Kim SJ, Lee H. The clinical study on 193 cases with herniated lumbar disc. J Daejeon Oriental Med 2011;19(1):119–28.
9. Lee EK, Choi EH, Lee JE, et al. The clinical study on 137 cases of herniated lumbar disc patients. The Acupuncture 2008;25(3):127–38.
10. Ahn MS, Park JS, Kwon YM, et al. The relationship between reduction of muscluloskeletal pain and quality of life treated with Korean traditional medicine. The Acupuncture 2010;27(5):35–42.
11. Kim SY, Park HS, Kim MC, et al. Effects of Korean medical combination treatment for herniated intervertebral lumbar disc patients: an observational study. The Acupuncture 2014;31(4):21–8.
12. Ahn SG, Lee SR, Yang YS. The treatise research on Hua-Tuo-Jia-Ji-Xue. The Acupuncture 2000;17(4):139–148.
13. Kim DW, Kim Y, Shin JS. The clinical effect of Cheongpa-jeon on the group of patients who were treated under conservative remedies for LBP(low back pain). Journal of Korea Chuna Manual Medicine 2004;5(1):85–92.
14. Kim YS, Chae WS. Clinical studies on the effects of the electrical acupuncture stimulation therapy of low back pain in lumbar spondylosis. The Acupuncture 1989;6(1):113–28.
15. Jeon CH, Kim DJ, Kim SK, Kim DJ, Lee HM, Park HJ. Validation in the Cross-cultural adaptation of the Korean version of the oswestry disability index. J Korean Med Sci 2006;21(6):1092–7.
16. Lee YK, Nam HS, Chuang LH, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 2009;12(8):1187–93.
17. Lee SI. Validity and reliability evaluation for EQ-5D in Korea [Internet] Korea Centers for Disease Control and Prevention; 2011. [cited 2012 March 08 ]. Available from: http://www.cdc.go.kr/CDC/contents/CdcKrContentLink.jsp?fid=28&cid=1742&ctype=1.
18. Robert M, Walter N. Diagnosis and treatment of pain of vertebral origin 2nd edth ed. Seoul: Koonja; 2008. p. 307.
19. Suk SI. Third edition textbook of spinal surgery Newest Medical Publishing Company; 2011. p. 301.
20. Jung JH, Kim WW, Seong IK, et al. The study on effectiveness of oriental medicine treatment for lumbar disc herniation inpatients on 208 cases. J Oriental Rehab Med 2013;23(1):77–86.
21. Jeong SH, Kim GT. Textbook of spinal disorders 1st edth ed. Seoul: Koonja; 2008. p. 188.

Article information Continued

Fig. 1.

Flow Diagram of Included Patients

Table 1.

Distribution of Sex and Age

N %
Sex Male 32 44.4
Female 40 55.6
Age 20~29 15 20.8
30~39 19 26.4
40~49 8 11.1
50~59 17 23.6
60~69 10 13.9
70~ 3 4.2
Total 72 100

Table 2.

Distribution of Causes

N %
Reason unknown 36 50
Lumbar strain 12 16.7
Same motion in long period 3 4.2
Overwork 9 12.5
Traffic accident 4 5.6
Slip down 7 9.7
Cough 1 1.4
Total 72 100

Table 3.

Distribution of Period of Illness

N %
Hyperacute stage 21 29.2
Acute stage 15 20.8
Subacute stage 14 19.4
Chronic stage 22 30.6
Total 72 100

Table 4.

Distribution of Admission Days

N %
0~5 1 1.4
6~10 3 4.2
11~15 11 15.3
16~20 9 12.5
21~25 8 11.1
26~30 11 15.3
31~35 9 12.5
36~40 5 6.9
41~45 7 9.7
46~50 6 8.3
51~ 2 2.8
Total 72 100

Table 5.

Distribution of Numbers, Grade and Position of Herniation

N %
Numbers 1 16 22.2
2 23 31.9
3 25 34.7
4 6 8.3
5 2 2.8
Grade Bulging 9 12.5
Protrusion 35 48.6
Extrusion 28 38.9
Position L1 / 2 0 0
L2 / 3 1 1.4
L3 / 4 2 2.8
L4 / 5 45 62.5
L5 / S1 24 33.3
Total 72 100

Table 6.

Distribution of Pain Area

N %
Just lumbar pain 3 4.2
Lumbar and pelvis pain 5 6.9
From lumbar to thigh pain 0 0
Lumbar and whole leg pain 64 88.9
Total 72 100

Table 7.

Lumbar Pain NRS Difference before and after Treatment

N NRS p-value
Before After
Sex Male 32 5.53±2.21 2.81±1.47 p<0.001***
Female 40 6.18±1.78 3.90±2.02
Age <40 34 5.56±2.06 2.85±1.28
≥40 38 6.18±1.92 3.92±2.16
Period of disease Hyperacute stage 21 6.71±2.22 3.43±2.04
Acute stage 15 5.07±1.67 3.20±1.47
Subacute stage 14 6.00±1.52 3.64±1.78
Chronic stage 22 5.59±2.06 3.41±2.09
Total 72 5.89±2.00 3.42±1.87

Average NRS values are means ± standard deviation. p-value by paired t-test in before and after NRS.

***

p<0.001.

Table 8.

Radiating Pain NRS Difference before and after Treatment

N NRS p-value
Before After
Pain area Pelvis pain 5 6.60±2.19 2.80±1.30 0.012*
Thigh pain 0 0 0
Whole leg pain 64 5.91±2.13 3.42±1.87 p<0.001***
Sex Male 29 5.90±2.34 2.76±1.43
Female 40 6.00±1.99 3.83±1.97
Age <40 32 5.72±2.37 2.84±1.42
≥40 37 6.16±1.89 3.84±2.03
Period of disease Hyperacute stage 20 7.10±2.00 3.55±1.76
Acute stage 15 5.47±1.88 3.33±1.54
Subacute stage 14 6.14±1.23 3.43±1.74
Chronic stage 20 5.05±2.46 3.20±2.24
Total 69 5.96±2.12 3.38±1.83

Average NRS values are means ± standard deviation. p-value by paired t-test in before and after NRS.

*

p<0.05.

***

p<0.001.

Table 9.

ODI Difference before and after Treatment

N ODI p-value
Before After
Sex Male 32 44.01±21.51 30.17±13.68 0.001**
Female 40 48.83±17.22 40.12±17.66 p<0.001***
Age <40 34 42.20±20.53 29.89±14.18
≥40 38 50.70±17.33 40.89±17.18
Period of disease Hyperacute stage 21 60.35±21.47 38.48±21.97
Acute stage 15 42.25±16.36 35.63±13.66 0.010**
Subacute stage 14 44.56±12.97 34.83±13.10 p<0.001***
Chronic stage 22 38.03±15.78 33.64±15.37 0.004**
Total 72 46.69±19.25 35.69±16.67 p<0.001***

ODI values are means ± standard deviation. p-value by paired t-test in before and after ODI.

**

p<0.01.

***

p<0.001.

Table 10.

EQ-5D Index Difference before and after Treatment

N EQ-5D index p-value
Before After
Sex Male 32 0.64±0.29 0.75±0.17 0.025*
Female 40 0.63±0.22 0.67±0.21 0.029*
Age <40 34 0.67±0.26 0.75±0.16 0.041*
≥40 38 0.60±0.25 0.67±0.22 0.029*
Period of disease Hyperacute stage 21 0.42±0.33 0.63±0.27 0.013*
Acute stage 15 0.74±0.10 0.77±0.06 0.140
Subacute stage 14 0.67±0.25 0.70±0.25 0.067
Chronic stage 22 0.73±0.09 0.74±0.10 0.029*
Total 72 0.63±0.26 0.71±0.20 0.003**

EQ-5D index values are means ± standard deviation. p-value by paired t-test in before and after EQ-5D index.

*

p<0.05.

**

p<0.01.